Pieris Pharmaceuticals, Inc. (PIRS) Financials
Stock symbol PIRS is outdated, potentially delisted? Maybe it is available on other exchange?
PIRS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2024 | 20.5 million | 4.3 million |
| June 30, 2024 | 25.1 million | 6.3 million |
| March 31, 2024 | 29.5 million | 7.5 million |
| Dec. 31, 2023 | 38.7 million | 11.9 million |
PIRS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2024 | 146000 | 330000 |
| June 30, 2024 | -1.5 million | 421000 |
| March 31, 2024 | -7.0 million | 472000 |
| Dec. 31, 2023 | -19.7 million | 451000 |
PIRS Net Income
No data available :(
PIRS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2024 | 19.4 million | - | - |
| June 30, 2024 | 19.7 million | - | - |
| March 31, 2024 | 19.1 million | - | - |
| Dec. 31, 2023 | 26.4 million | - | - |
PIRS Shares Outstanding
PIRS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2024 | - | 446000 | 3.6 million | - |
| June 30, 2024 | - | 751000 | 3.4 million | - |
| March 31, 2024 | 13000 | 1.2 million | 4.1 million | - |
| Dec. 31, 2023 | 13000 | 4.5 million | 2.3 million | - |
PIRS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2024 | - | - |
| June 30, 2024 | - | 751000 |
| March 31, 2024 | 53000 | -30000 |
| Dec. 31, 2023 | 1.3 million | 4.5 million |
PIRS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
PIRS
Price: $13.60
52 week price:
Earnings Per Share: -12.11 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 522800
Ebitda: -5.1 millionMarket Capitalization: 21.9 million